Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Dolasetron mesylate |
Is a |
False |
Dolasetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing dolasetron (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dolasetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely dolasetron mesilate 20 milligram/1 ampule powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dolasetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dolasetron mesylate monohydr 50mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dolasetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely dolasetron mesilate 100 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dolasetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dolasetron mesylate monohydr 100mg/5 mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dolasetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely dolasetron mesilate 50 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dolasetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely dolasetron mesilate 200 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dolasetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dolasetron mesilate 20mg/mL injection solution 0.625mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dolasetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dolasetron mesilate 20mg/mL injection solution 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dolasetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing dolasetron in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dolasetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dolasetron-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dolasetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dolasetron mesylate |
Is modification of (attribute) |
True |
Dolasetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing only dolasetron (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dolasetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dolasetron only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dolasetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dolasetron only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dolasetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |